When the drug is added under hypoxic conditions, other pathways/processes become more important, including those related to central carbon metabolism in cancer, small-cell lung cancer, glycolysis/gluconeogenesis, HIF-1 signaling, and focal adhesion (Figure 3C). Here, HIF1A is linked to small cell lung carcinoma.